BioCentury
ARTICLE | Clinical News

Hexvix hexyl aminolevulinate regulatory update

December 21, 2009 8:00 AM UTC

FDA's Oncologic Drugs Advisory Committee voted 9-8 that Photocure has demonstrated a favorable benefit-risk profile for Hexvix to detect papillary bladder cancer using fluorescence cystoscopy. The ami...